Alnylam Pharmaceuticals (ALNY) P/FCF US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
P/FCF | -30.1 | -21.8 | -28.0 | -47.2 | 570.0 | 1 293 | ||
Changes by years, y/y, % | +183% | -27% | +28% | +69% | -1 309% |
Alnylam Pharmaceuticals. P/FCF
Alnylam Pharmaceuticals. P/FCF, changes, %
Alnylam Pharmaceuticals (ALNY) P/FCF US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
P/FCF | -333.2 | 573.2 | 147.5 | 96.6 | 2 202 | 1 293 | ||
Changes by years, y/y, % | +761% | -1 300% | -459% | -321% | -761% | |||
Changes by quarters, q/q, % | +661% | -272% | -74% | -35% | +2 180% |